Vaxcyte Inc annual gross profit for fiscal 2024 was -$16 million, an increase of 78.7% from -$75 million in fiscal 2023. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Profit | — | — | ($16M) | ($75M) | ($9M) | ($2M) | ($1M) | ($1M) | ($1M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Gross Profit | — | ($6M) | $5M | — | ($5M) | — | — | ($5M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More PCVX metrics: Revenue · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All PCVX financial statements → Interactive PCVX charts →
About TickerBase · Data methodology & sources · Privacy · Terms